<DOC>
	<DOC>NCT02149784</DOC>
	<brief_summary>There is still no perfect treatment suggestion for patients with asymptomatic colorectal cancer with unresectable metastatic disease. Whether patients can benefit from palliative resection of primary tumor or not is still waiting for answer. The investigators hypothesis that asymptomatic metastatic colorectal cancer patients who respond to chemotherapy will benefit from primary tumor resection.</brief_summary>
	<brief_title>Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>18 to 70 years old both genders ECOG:02 score Pathological confirmed colon cancer or rectal cancer with at least 12 cm far away from anal verge CT,MRI,or PETCT confirmed metastasis MDT confirmed unresectable metastasis lesion No evidence of obstruction, bleeding, perforation WBC≥4.0×109/L，Neu ≥2.0×109/L，PLT≥100×109/L No contraindication for chemotherapy No evidence of other malignant tumor Expected survival time &gt; 6 months mCRC patients who did not respond to first line chemotherapy Require surgical intervention during the primary tumorrelated symptoms Obvious coagulopathy Severe heart, liver, kidney damage or other serious uncontrolled medical illness or acute infection, cachexia Severe organ damage after chemotherapy, surgery or unable to continue to systemic chemotherapy Pregnant or lactating women or women of childbearing age who refuse to accept contraception. Nearly three months participated in clinical trials of other persons. Mental abnormalities</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Metastasis colorectal cancer</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Resection of primary tumor</keyword>
</DOC>